These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12204715

  • 1. Histology and fine structure of the iris and outflow system following latanoprost therapy.
    Grierson I, Pfeiffer N, Cracknell KP, Appleton P.
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S176-84. PubMed ID: 12204715
    [Abstract] [Full Text] [Related]

  • 2. Morphometric effects of long-term exposure to latanoprost.
    Cracknell KP, Grierson I, Hogg P.
    Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473
    [Abstract] [Full Text] [Related]

  • 3. Iris morphology.
    Teus MA, Arranz-Marquez E.
    Ophthalmology; 2008 Feb; 115(2):418-9; author reply 419-20. PubMed ID: 18243921
    [No Abstract] [Full Text] [Related]

  • 4. Evidence of early change in iris color with latanoprost use.
    Pappas RM, Pusin S, Higginbotham EJ.
    Arch Ophthalmol; 1998 Aug; 116(8):1115-6. PubMed ID: 9715697
    [No Abstract] [Full Text] [Related]

  • 5. Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies.
    Cracknell KP, Grierson I, Hogg P, Appleton P, Pfeiffer N.
    Exp Eye Res; 2003 Dec; 77(6):721-30. PubMed ID: 14609560
    [Abstract] [Full Text] [Related]

  • 6. Analysis of irises with a latanoprost-induced change in iris color.
    Arranz-Marquez E, Teus MA, Saornil MA, Mendez MC, Gil R.
    Am J Ophthalmol; 2004 Oct; 138(4):625-30. PubMed ID: 15488791
    [Abstract] [Full Text] [Related]

  • 7. The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change.
    Grierson I, Lee WR, Albert DM.
    Arch Ophthalmol; 1999 Mar; 117(3):394-6. PubMed ID: 10088822
    [No Abstract] [Full Text] [Related]

  • 8. A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients.
    Albert DM, Gangnon RE, Zimbric ML, Damico CM, Fisher MR, Gleiser J, Grossniklaus HE, Green WR.
    Arch Ophthalmol; 2004 Nov; 122(11):1680-5. PubMed ID: 15534130
    [Abstract] [Full Text] [Related]

  • 9. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
    Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ.
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
    [Abstract] [Full Text] [Related]

  • 10. Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study).
    Pfeiffer N, Grierson I, Goldsmith H, Appleton P, Hochgesand D, Winkgen A.
    Arch Ophthalmol; 2003 Jan; 121(1):23-31. PubMed ID: 12523881
    [Abstract] [Full Text] [Related]

  • 11. Latanoprost-induced iris color darkening: a case report with long-term follow-up.
    Camras CB, Neely DG, Weiss EL.
    J Glaucoma; 2000 Feb; 9(1):95-8. PubMed ID: 10708238
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Latanoprost and pigmentation.
    Grierson I, Jonsson M, Cracknell K.
    Jpn J Ophthalmol; 2004 Feb; 48(6):602-12. PubMed ID: 15592791
    [Abstract] [Full Text] [Related]

  • 14. A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.
    Albert DM, Gangnon RE, Grossniklaus HE, Green WR, Darjatmoko S, Kulkarni AD.
    Arch Ophthalmol; 2008 May; 126(5):626-31. PubMed ID: 18474771
    [Abstract] [Full Text] [Related]

  • 15. Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients.
    Chiba T, Kashiwagi K, Kogure S, Abe K, Shibuya T, Furuichi M, Iijima H, Tsukahara S.
    J Glaucoma; 2001 Oct; 10(5):406-10. PubMed ID: 11711839
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of a latanoprost-induced increase in iris pigmentation in Japanese eyes.
    Latanoprost-Induced Iris Pigmentation Study Group.
    Jpn J Ophthalmol; 2006 Oct; 50(2):96-9. PubMed ID: 16604382
    [Abstract] [Full Text] [Related]

  • 18. Latanoprost-induced changes in the iris and trabeculum: an electron-microscopic morphological study.
    Yildirim N, Sahin A, Kara S, Baycu C.
    Int Ophthalmol; 2010 Feb; 30(1):93-7. PubMed ID: 19139827
    [Abstract] [Full Text] [Related]

  • 19. Increased iris pigment in a child due to latanoprost.
    Brown SM.
    Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
    [No Abstract] [Full Text] [Related]

  • 20. The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation.
    Imesch PD, Wallow IH, Albert DM.
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S117-23. PubMed ID: 9154287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.